Get it on Google Play

Immunic to present MS drug data at Toronto conference

October 7, 2026 8:00 AM EDT Send to a Friend
Immunic, Inc. (Nasdaq: IMUX) announced that four abstracts on its investigational drug vidofludimus calcium (IMU-838) have been accepted for presentation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login